Editor's Note The common practice of administering potassium after bypass surgery can be safely abandoned in patients with normal blood levels, according to results of the randomized TIGHT-K trial. According to a September 3 report in Medscape, potassium supplementation is a widely accepted means of reducing the risk of postoperative…

Read More

Editor's Note A new study, the Stop-or-Not Trial, has found no significant difference in outcomes for patients undergoing noncardiac surgery who either continued or discontinued their renin-angiotensin system (RAS) inhibitor therapy, MedPage Today August 31 reports. The randomized clinical trial, which included over 2,200 patients, reported the rate of death…

Read More

Editor's Note A recent study from two tertiary care centers highlighted significant sex differences in long-term outcomes after cardiac surgery, especially concerning postoperative atrial fibrillation (postopAF), MedPage August 21 reports. The study, published in JAMA Network, found that while women were less likely than men to develop postopAF following a…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

Editor's Note This new multicenter study published by the Heart Rhythm Society on August 5 found that ambulatory surgery centers (ASCs) offer a safe and effective setting for performing various cardiac electrophysiology procedures, including catheter ablation (CA). The research, which retrospectively analyzed 4,037 procedures, highlights the viability of ASCs as…

Read More

Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…

Read More

Editor's Note Female patients undergoing heart surgery are less likely than male patients to have concomitant procedures—that is, having additional ailments addressed during cardiac procedures—despite guidelines recommending such treatments, according to two studies led by Michigan Medicine. News-Medical.Net reported the news June 28. The first study, involving over 5,000 patients…

Read More

Editor's Note The US Food and Drug Administration has announced class 1 recalls—the most severe category indicating risk of serious injury or death—for Abbot Medical’s HeartMate System Monitor and Philips Respironics OmniLab Advanced+ (OLA+) ventilator. According to the agency’s June 28 report, the recall of the HeartMate System Monitor, part…

Read More

Editor's Note The largest scale analysis so far available comparing surgical aortic valve replacement (SAVR) to longer-term percutaneous devices for transcatheter aortic valve replacement (TAVR) supports the comparable long-term safety and efficacy of the latter procedure. According to a May 15 report in Medical Xpress, the findings raise important considerations for valve…

Read More

Editor's Note The lack of available hearts for transplantation combined with the recent recall of Abbott’s HeartMate 3 left ventricular assist device (LVAD) “makes the current therapy landscape for heart failure much more dire,” according to a May 20 report in Medical Device Network. The recall of the device, which…

Read More